A phase 3 trial of elderly patients with nonsquamous NSCLC demonstrated that carboplatin + pemetrexed prolonged survival with an improved safety profile compared with docetaxel.
Neoadjuvant chemotherapy was found to negatively impact survival in resectable malignant pleural mesothelioma.
The researchers noted that medical distancing for those with cancer could help prevent the spread of the virus in this highly vulnerable population.
The best bet for a new company hoping to deliver on a lofty promise to “remake medicine” could rely on drug repurposing.
The patient recovered from pneumonia and stable disease was observed.
Nonsignificant variation of acquired resistance occurred by drug type.
Screening patients by phone before they come to a clinic may help to eliminate potentially redundant visits and lower the risk of infection.
57 percent have spirometry findings consistent with COPD, 67 percent do not have prior history of COPD.
Chemotherapeutic and biologic agents for the treatment of non-small cell lung cancer (NSCLC).
Optimal combinations of MEK, ROS1 inhibitors should be explored.
